Have a personal or library account? Click to login
Comparative study of low dose of capecitabine versus standard dose in metastatic breast cancer: Efficacy and safety Cover

Comparative study of low dose of capecitabine versus standard dose in metastatic breast cancer: Efficacy and safety

Open Access
|Aug 2021

Authors

Engy M Aboelnaga

engyms2007@gmail.com

Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Mansoura University, Egypt

Wafaa El-beshbishi

Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Mansoura University, Egypt
DOI: https://doi.org/10.2478/fco-2019-0015 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Page range: 12 - 21
Submitted on: Jul 5, 2019
|
Accepted on: Nov 5, 2019
|
Published on: Aug 9, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2021 Engy M Aboelnaga, Wafaa El-beshbishi, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.